M3 Wake Research runs clinical trials across North America and recruits volunteers for biopharmaceutical and device sponsors.
Founded in 1984 and headquartered in Raleigh, North Carolina, M3 Wake Research conducts clinical trials and research studies through a network of investigational sites. It works with biopharmaceutical, biotechnology and medical device companies and recruits patients and volunteers for studies, including cancer research. M3, Inc. acquired the company from Gemini Investors and Timepiece Capital in February 2018, and Ella Grach is the CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in